Clinical Trial Update: Safety and Effectiveness of Valbenazine as Adjunct Therapy to Botulinum Toxin Injections in Cervical Dystonia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating valbenazine as an adjunct to botulinum toxin injections for cervical dystonia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Dystonia

Drugs mentioned

• Valbenazine (valbenazine)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Cervical Dystonia | Phase 2 | Status: RECRUITING